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also been suggested as having a role in the prevention of periventricular hemorrhage, this potentially adverse effect is of concern (4, 5) .
The purpose of this study was to investigate in preterm infants the effects of i.v. indomethacin on cerebral intracellular oxygenation as judged by changes in the concentration of [CytOz] , using NIRS to quantify alterations in [Cyt02] and cerebral hemodynamics. Cytochrome oxidase is the terminal enzyme of the mitochondrial electron transport chain. There is evidence that, as intramitochondrial PO, falls to low levels, the enzyme becomes progressively reduced (6, 7) . Thus, if indomethacin significantly reduced intramitochondrial oxygen tension, [CytOz] should fall. Because of the possibility that indomethacin might have additional effects, causing changes in [CytOz] that were not related to intramitochondrial oxygen tension, we have also investigated the effect of indomethacin on the respiratory rate of isolated synaptic terminals of brain neurons (synaptosomes).
MATERIALS AND METHODS
Subjects. Fifteen newborn infants who had been admitted to the neonatal unit of University College Hospital and who were receiving indomethacin for treatment of PDA were studied. Seven were male, and eight were female. Their gestational ages ranged from 23 to 29 (median 26) wk and their birth weights from 600 to 1590 (median 860) g. The diagnosis of clinically significant PDA was made when the characteristic cardiac murmur was associated with bounding peripheral pulses and an enlarged liver, and in each infant the diagnosis was confirmed by echocardiography. Indomethacin was administered into a peripheral vein in a dose of either 0.1 or 0.2 mg.kggl; eight infants received indomethacin by fast infusion over 30 s, and seven by slow infusion over 20 to 30 min. All infants suffered from hyaline membrane disease or chronic lung disease and were studied during the first dose of indomethacin. Clinical details and cranial ultrasound findings for the infants studied are listed in Table I . Data for CBF, COD, CBV, and CBVR in nine of these infants have been reported previously (1).
Consent for the investigation was obtained from each infant's parents before each study and the project was approved by the University College London Faculty of Clinical Sciences Committee on the Ethics of Clinical Investigation.
NZRS. This technique depends on the characteristic absorption by the chromophores Hb02, Hb, and Cyt02 of near-infrared light transmitted through the head. Changes in chromophore concentration can be calculated from changes in light absorption using a modification of the Beer-Lambert law, which describes optical absorption in a highly scattering medium:
where a is the absorption coefficient of the chromophore (mM-' cm-I), c is the concentration of the chromophore (mM), L is the distance between the points where light enters and leaves the 604 MCCORMICK ET AL tissue (cm), B is a "pathlength factor" that takes account of the scattering of light in tissue (which causes the optical pathlength to be greater than L), and G is a factor related to the tissue type and measurement geometry (8) . If L, B, and G remain constant during a measurement, changes in chromophore concentration can be obtained from the expression:
The absorption coefficients of Cyt02, Hb02, and Hb are known (9, lo), and a mean value for B of 4.39 has been obtained from the time of flight of photons through the neonatal brain (1 I). Details of the NIRS system, which was developed at this institution, have been described elsewhere (9) . For this study, a commercial prototype spectrophotometer (NIR 1000, Hamamatsu Photonics KK, Hamamatsu City, Japan) was used. Nearinfrared light at six wavelengths (779, 803, 831, 849, 867, and 908 nm) was conveyed to the infant's head via a flexible fiber optic bundle. The end of the fiber (the "optode") was applied to the parietal area, and transmitted light emerging from the opposite parietal region was collected by another optode and fiber optic bundle leading to the photomultiplier detector in the NIR 1000. The distance between the optodes was measured using mechanical calipers. Changes in [Cyt02], [Hb02], and [Hb] were calculated from the changes in optical absorption using the linear least squares curve-fitting technique with the absorption coefficients and algorithms described previously (10, 12) . To assess the stability of the technique, measurements were made every 20 s on an infant who was undergoing intensive care but was undisturbed during the 60-min measurement period. The SD of repeated measurements of [Cyt02] during this defined steady state was 0.0 1 Fmol. L-I, with no significant increase or decrease. The average SD for measurements of A[CytO2] in the study group during the 5-min period before the administration of indomethacin was 0.15 ILmol. mL-I.
Procedure. The infants were studied continuously for 31 to 203 (median 100) min before indomethacin administration commenced and for 49 to 238 (median 89) min after it was completed. During this period, Pao2 and Paco2 were estimated continuously using a Novametrix 850 (Novametrix, Wallingford, CT) transcutaneous electrode calibrated from analysis of arterial blood. Arterial oxygen saturation (Sao2) was measured on every pulse beat using either a modified Novametrix 500 (Novametrix) or Nellcor (Nellcor Type BF, Nellcor Inc, Haywood, CA) pulse oximeter whose probe was sited on the ear or the lip. MABP was measured before and after indomethacin administration by an oscillometric method (Dinamap 1846SX, Critikon Corp, FL). Arterial Hb concentration was estimated by Coulter counter on a sample of blood drawn from the aorta (via a 3.5 or 5 French gauge catheter in the umbilical artery) or a peripheral artery. Cranial ultrasonography was performed using a 7.5-MHz mechanical sector scanner (ATL 4, ATL Ltd., Letchworth, UK). Blood glucose concentration was not assessed in detail, but in all infants, values greater than 2 mmol . L-' were obtained at regular bedside testing (BMstix, Boehringer Mannheim, Mannheim, Germany) around the time of indomethacin administration.
Changes in [Cyt02], [Hb02], and [Hb] were recorded continuously and averaged over 20-s periods for display at the cotside. The data were also stored on computer disc for later analysis. CBF, CBV, and CBVR were estimated both before and after indomethacin administration by the methods described previously (1 3-15). CBF measurement was possible in only 1 1 of the 15 infants studied and was measured one to six (median three) times 6 to 189 min before indomethacin and between one and eight (median three) times 5 to 110 min afterwards, with values from repeated measurements being averaged for further analysis. COD was calculated as the product of arterial oxygen concentration and CBF. CBV was measured continuously in all infants, and CBVR was measured in each infant once 5 to 120 min before and once 10 to 96 min after injection. A period of stability in clinical variables and the cotside display of the [Cyt02] signal lasting at least 5 min was required before the indomethacin was given, and changes in [CytO*] were observed from the continuous data.
Data analysis. Baseline values for [Cyt02] were calculated as the mean of observations made every 20 s during the 5-min periods immediately before the indomethacin infusion started and after it ended. The standard error of the difference between the two means was calculated for each infant using a standard formula for samples where the variances may differ considerably (1 6), and the significance of the difference was assessed according to Welch (1 7). Values o f p that were less than 0.01 were regarded as significant.
The averaged values for CBF, COD, CBV, and CBVR before and after indomethacin for each infant were compared using paired t test. The extent of change in these variables and in mean [Cyt02] were compared between the fast and slow infusion groups and between the groups receiving 0.1 or 0.2 mg.kg-' using unpaired t test. Synaptosome study. To investigate any direct effect of indomethacin on mitochondria1 respiration, synaptosomes were isolated from the whole brains of 1-mo-old female Wistar rats by density-gradient centrifugation. Synaptosomes consist of presynaptic membrane surrounding cytosol, synaptic vesicles, and mitochondria, and provide a convenient in vitro model for studies of brain metabolism (1 8). Synaptosomal oxygen consumption reflects energy turnover, which depends on the rates of mitochondrial ATP production and consumption, providing a direct assay of the activity of cytochrome oxidase. The effect of indomethacin on synaptosomal oxygen consumption was assayed either in the absence or presence of veratridine, which maximally stimulates respiration by opening sodium channels in the plasma membrane. Veratridine-treated preparations provide a model of maximally active neurons, whereas untreated preparations simulate inactive cells.
Synaptosomal protein was assayed by the Lowry method, with BSA as a standard, and synaptosomes were incubated at 0.6 mg protein. mL-' in a Krebs phosphate-plus-glucose medium at 37°C (1 8). Mitochondria1 respiration was measured continuously as oxygen consumption by a Clarke-type oxygen electrode (Rank, Bottisham, UK). Synaptosomes were preincubated in the oxygen electrode vessel for 10 min, and then indomethacin (dissolved in DMSO) was added at a range of concentrations. Three separate synaptosome preparations were used and nine determinations of oxygen consumption were made between 1 and 5 min after the addition of indomethacin. Alternatively, the synaptosomes were preincubated for 5 min; then 50 pM veratridine were added, followed by indomethacin 5 min later. Here, six determinations of oxygen consumption in three separate preparations were made 1 to 5 min after indomethacin.
RESULTS

Cerebral dfects of indomethacin in newborn infants.
As previously reported (I), average CBF, CBV, and CBVR all fell significantly after indomethacin administration ( p < 0.01). No significant difference in the extent of change of values for hemodynamic variables was found between the fast and slow infusion groups or between the groups receiving different doses of the drug; Table 2 therefore summarizes the hemodynamic data for the entire study group. Effects of indomethacin on synaptosomal respiration. Veratridine increased synaptosomal oxygen consumption to a mean of 204% (SD 13%) of control values. In concentrations of less than 5 pg.mLW', indomethacin did not alter oxygen consumption either in the resting or the veratridine-stimulated preparations. Concentrations greater than 100 pg. mL-' were associated with a marked decline in oxygen consumption in veratridine-treated synaptosomes; half-inhibition of respiration occurred at approximately 150 pg.mL-' or 250 pg.mg-' protein. In untreated preparations, concentrations of indomethacin in excess of 100 pg.mL-' initially stimulated and then inhibited oxygen consumption. These results are given in Figure 3 . DMSO had no effect on synaptosomal oxygen consumption.
DISCUSSION
Accuracy ofNIRS. The accuracy of NIRS for detecting changes of cerebral [Cyt02] in preterm infants has been discussed previously (1 9). Precise determination of changes in [CytOz] requires accurate data for the absorption spectra of all mobile chromophores present and validity of the modified Beer-Lambert relationship. Near infrared spectra for Hb have now been measured under carefully controlled conditions by several groups (6, 10, 20) , and spectra for cytochrome oxidase obtained both from Hbfree animals in vivo (10, 21, 22) and from purified cytochrome extracts (23) . Recent studies have shown that spectra measured in vivo and in vitro are identical (6) and confirmed that the brain normally contains only three mobile chromophores (24) . The validity of the modified Beer-Lambert law in biologic tissue has been demonstrated both by theoretical modeling and experimental measurement (8) and is further supported by the close match between spectra measured in vivo and in vitro (6) .
Measurements of changes in the attenuation of light at six wavelengths were analyzed using a linear least-squares technique. This allows calculation of changes in chromophore concentration together with the residual error. Analysis of residuals has shown them to be small, confirming that the data fit a three-chromophore model quite precisely (19) . In a previous study using both linear and nonlinear analysis of spectra measured in rat brain, the latter method provided a more accurate fit, but the errors induced by linear calculation were small (6, 12) . System noise and systematic error are a small fraction of the total signal (1 9).
Cerebral dfects of indomethacin. Indomethacin is a potent inhibitor of cerebral prostanoid synthesis (25) . Studies in newborn piglets suggest that vasodilator prostaglandins maintain CBF during hypotension (26) and high-pressure mechanical ventilation (27) , although the increase in CBF that occurs during asphyxia is not prevented by indomethacin (28) . Prostanoids are probably important in the coupling of CBF to brain energy metabolism, and indomethacin is thought to reduce CBF without directly affecting cerebral oxygen consumption (25) . However, indomethacin causes different effects in some other species, and Table 2 . Hemodynamic data* CBF (mL. 100 g-' .
min-')t ' OD (mL' loo g-'. CBV (mL. 100 g-')$ CBVR (mL. 100 g-'.kPa-I)$ min-')t extrapolation of such data to human infants requires circumspection (25) . Indomethacin reduces CBF, COD, CBV, and CBVR in newborn infants suffering from PDA (1, 2), and the hemodynamic data presented previously (1) and in this report confirm that marked changes took place in the infants studied.
Cytochrome oxidase in the brain. Cytochrome oxidase is composed of 13 protein subunits, two heme units (A and A3), and two copper atoms (CUA and CuB) (29) . The CuB and heme A3 form a binuclear unit that receives electrons from heme A and CUA moieties and is the final electron donor to dioxygen in the reaction that forms water (30) ; this reaction accounts for the great majority of oxygen consumption in biologic tissue (31) . Electrons pass to from cytochrorne c, and the oxidation levels of cytochrome c and CuA are similar under most conditions (32,33). Absorption of near-infrared light by cytochrome oxidase occurs almost entirely at the center, the oxidized form of CUA having a characteristic spectrum, whereas the reduced form has no distinguishable absorption (23) . Near infrared measurements of changes in [CytOz] thus measure alterations in the concentration of oxygenated CuA and reflect the concentration of oxidized cytochrome c.
The concentration of oxidized CuA depends on the supply of oxygen, the availability of respiratory electrons and the level of the mitochondrial proton-motive force, determined mainly by the rate of cellular ATP utilization (32, 33). Variations in oxygen delivery and consumption in brain produce heterogeneous tissue oxygen concentrations, distributed between 1 and 100 pM, with a median value of about 40 PM (34, 35) . Measurements in isolated mitochondria have shown that the concentration of oxidized cytochrome c begins to decrease at oxygen concentrations below 20 pM, although the respiration rate does not fall until the oxygen concentration is below 1 to 5 pM (23); thus, a decrease in oxidized cytochrome c is not necessarily equivalent to a fall in mitochondrial respiration rate. A decline in [CytOz] may therefore demonstrate an increase in the fraction of brain where mitochondrial oxygen tension is below 20 pM. However, changes in [Cyt02] might also be precipitated by alterations in the rate of ATP utilization, changes in the supply of reducing equivalents, or the direct effect of drugs on mitochondrial function.
Changes in [Cyt02] after indomethacin. Significant falls in [Cyt02] were recorded in 1 1 of the 15 infants studied. No differences were detected between the effects of rapid and slow infusions of indomethacin or between different doses, but, inasmuch as the study did not address these questions directly, firm conclusions on dosage effects would be unwarranted.
The concentration of cytochrome oxidase in rat brain is approximately 5 pM (36) . The concentration in the newborn infant's brain has not been measured, but if it is similar, then the decreases in [CytOz] observed in this study constitute between approximately 3 and 20% of the total concentration.
The 5-min periods chosen before beginning and after ending indomethacin infusions appeared to encompass most of the observed alterations in [Cyt02]. However, it can be seen in Figure  IA that a mean calculated over the 5-min period immediately after fast infusion of indomethacin may underestimate the maximum change in [CytOz] . For some infants receiving indomethacin by slow infusion, the maximum changes were also sometimes underestimated, because some infants showed an initial fall in [Cyt02] followed by recovery before the infusion had finished.
Mechanism of effect of indomethacin on [Cyt02]. Indomethacin is unlikely to have affected mitochondria directly. Mitochondria1 respiration rate in synaptosomes did not change at concentrations of up to 5 pg.mL-', and, in preterm infants, serum levels after therapeutic indomethacin administration are less than 2 INDOMETHACIN AND CEREE IRAL CYTOCHROME OXIDASE 607 pg. mL-' (37) . Because indomethacin binds strongly to proteins, it may be more relevant to compare doses per mg of protein. Doses of up to 10 pg. mg-' protein caused no change in synaptosomal respiration. Infusion of 0.2 mg. kg-' of indomethacin is equivalent to 2 ng indomethacin.mg-' body protein (38) . Although the synaptosomes were derived from adult rat brain, any mechanism by which indomethacin could affect energy metabolism directly is unlikely to differ dramatically between the two systems. The decline in [Cyt02] seen in the study group is thus probably better explained by changes in intracellular oxygenation caused by the hemodynamic effects of indomethacin than direct effects on cerebral energy metabolism.
However, a simple relation between COD and [CytOz] has not emerged from this study; indeed, given the complexity of cerebral metabolic control, such a relation should not be expected. Both the mitochondria1 respiration rate and the oxidation-reduction state of respiratory chain components change their dependence on oxygen concentration dramatically under different metabolic conditions (39) . The variables studied would not have revealed metabolic heterogeneities that could modulate alterations in [CytOz] . The supply of respiratory electrons to mitochondria was not measured. and this may have been affected by differences in glucose metabolism. Cerebral glucose delivery, and ultimately the supply of reducing equivalents, would have declined with COD as CBF fell. Equally, cerebral ATP utilization was not assessed and may have been heterogeneous. [Cyt02] is thus a complex function of many variables and will not depend only on COD.
In addition, regional perfusion may have been altered. Energy metabolism in brain closely parallels CBF (31) and capillary density (40). Disruption of this precise relation might reduce substrate delivery to metabolically active regions even if total CBF did not alter significantly, with a consequent fall in [Cyt02] . In a previous study, we offered evidence to suggest that microvascular alterations had a marked effect on [CytOz] (19) . Again, the preexisting distribution of intracellular oxygen tensions would have significant effects on resulting alterations in [Cyt02].It is also possible that effects on vascular control varied as a result of different serum levels of indomethacin; there may be considerable variation in serum indomethacin concentration after the same dose in different babies (41).
Conclusions. Administration of indomethacin significantly reduced [Cyt02] in the majority of infants studied, whereas equipotent concentrations of indomethacin had no effect on oxygen metabolism in synaptosomes. This is consistent with the hypothesis that [CytOz] declined as a result of alterations in intracellular oxygen availability due to hemodynamic perturbations. However, metabolic and hemodynamic heterogeneity prevent the finding of a simple relation between COD and [Cyt02].
